Dividend Stocks I Bought in August

I have been working on diversifying my portfolio recently, so I’ve sold some of my positions and bought new ones this month.

Main Street Capital (MAIN)

The very first stock I bought for August is Main Street Capital (MAIN).

If you don’t know what MAIN is, it’s a Business Development Company, or BDC, that engages in “providing long-term debt and equity capital to lower middle market companies and debt capital to middle market companies.”

They loan out money to businesses who need money in order to grow their operations. MAIN then makes money from these loans, and a portion of their profits are given to shareholders like me in the form of distributions.

There were 3 transactions for MAIN in August:

The first purchase was on August 3, and I purchased 0.35 share to complete my fractional share for MAIN. I purchased the share at a price of $41.15. At that time, it brought my MAIN holding to a complete 1 share.

The second purchase was on August 10, and I purchased 1 share at $42 through a limit order. I remember doing this purchase with a limit order because I wanted to get the lowest possible price I could get. The lowest it went for that day was $41.95 and the highest at $42.58. So I got in at a good price.

The third purchase was on August 20, and I purchased 2 shares at $41.90. I missed out this day on getting MAIN at a cheaper price because it went below $41. I could’ve gotten it at $40.80, but I didn’t put a limit order at that price point.

With this 3 purchases, I own 4 shares of MAIN at an average cost of $41.77. And MAIN holds a position ratio of 2.29% in my portfolio.

Enterprise Products Partners LP (EPD)

The second stock I bought for August is Enterprise Products Partners LP (EPD).

EPD is a company that engages in the distribution and storage of energy. They provide midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products.

I also made 2 transactions for EPD in August:

The first purchase was on August 3, and I purchased 7 shares at $22.39. This stock was quite choppy back then and it still continues to slide to the current levels. I wanted to buy more since it was cheaper and really cash in on that 8% dividend yield.

The second purchase was on August 13, and I only purchased 1 share at $22.71. I wasn’t able to purchase at a lower price, and unfortunately, I ran out of funds to buy more.

With these 2 purchases, I own 11 shares of EPD at an average cost of $22.82. And EPD holds a position ratio of 3.34% in my portfolio.

New York Community Bancorp (NYCB)

The third stock I bought for August is New York Community Bancorp (NYCB).

This is a new addition to my portfolio. I stumbled upon it while doing some research on dividend stocks in the Financials sector because I also wanted to increase my allocation there.

NYCB provides banking products and services in Metro New York, New Jersey, Ohio, Florida, and Arizona. They offer a wide variety of typical banking products such as deposit products, including interest-bearing checking and money market, savings, non-interest-bearing, and individual retirement accounts. They also have loan products such as multi-family loans and commercial real estate loans.

I have 2 transactions for NYCB in August

This purchase was made on August 3. I purchased 5 shares at $11.87 through a limit order since I was hoping it would lower below $11.90, to which, it did. I got it cheaper than its day high of $12.15.

The second purchase was made on August 20, and I purchased 2 shares at $12.21. Same situation with my last MAIN purchase, I didn’t put a limit order for NYCB. If I did, maybe I could’ve gotten the 2 shares at $12. But it is what it is.

With these 2 purchases, I own 7 shares of NYCB at an average cost of $11.97, and it holds a position ratio of 1.18% in my portfolio.

AbbVie (ABBV)

The fourth stock I bought for August is AbbVie (ABBV).

This is another new addition to my portfolio, and it should really have a place in it. This is the first stock in my portfolio that is in the Healthcare sector.

If you don’t know, AbbVie discovers, develops, manufactures, and sells pharmaceuticals around the world. And their most popular product is HUMIRA, a therapy administered as an injection for autoimmune and intestinal diseases.

AbbVie has been a very popular dividend stock with dividend investors as well, and it’s for very good reasons too.

Anyway, I only have 1 transaction for ABBV in August:

This purchase was made on August 10. I purchased 2 shares at $114.25 through a limit order. It’s always a great idea to put limit orders so that you can control the price you get in. And that’s how I’ve been doing it lately just so I can take advantage of any moment in which the stock drops in price.

I’m just happy right now that I have ABBV in my portfolio and my target of diversifying is coming to shape.

Plans Moving Forward

No purchases will be made at this point anymore since I’ve used up my recent deposit already. And any dividends I’m getting from this point will be reserved for next month instead. I’m thinking of simply adding more to my positions now instead of adding new positions. But, times change and I’ll adapt to what my portfolio needs if it comes to that point.

---

What stocks did you buy for August?